Issued Patents All Time
Showing 1–25 of 35 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12404491 | Methods for enhancing efficacy of therapeutic immune cells | Takahiro Kamiya | 2025-09-02 |
| 12404492 | Methods for enhancing efficacy of therapeutic immune cells | Takahiro Kamiya | 2025-09-02 |
| 12351617 | Immune cells comprising truncated NKG2D chimeric receptors | Jun Hao Leong, Noriko Shimasaki, See Voon Seow, James Barnaby Trager, Alexandra Leida Liana Lazetic +3 more | 2025-07-08 |
| 12264335 | Natural killer cells expressing membrane-bound interleukin 15 (mbIL15) and uses thereof | David Shook, Masaru Imamura | 2025-04-01 |
| 12258381 | Activating chimeric receptors and uses thereof in natural killer cell immunotherapy | See Voon Seow | 2025-03-25 |
| 12129485 | Blockade of CD2 surface expression and expression of chimeric antigen receptors for immunotherapy of T-cell malignancies | Natasha Vinanica, Yi Tian Png, Takahiro Kamiya | 2024-10-29 |
| 11945865 | Blockade of CD7 expression and chimeric antigen receptors for immunotherapy of T-cell malignancies | Yi Tian Png, Natasha Vinanica, Takahiro Kamiya | 2024-04-02 |
| 11896616 | Stimulatory cell lines for ex vivo expansion and activation of natural killer cells | Takahiro Kamiya | 2024-02-13 |
| 11873512 | Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious disease | Yu-Hsiang Chang | 2024-01-16 |
| 11709164 | Approach for universal monitoring of minimal residual disease in acute myeloid leukemia | Elaine Coustan-Smith | 2023-07-25 |
| 11679132 | Methods for enhancing efficacy of therapeutic immune cells | Takahiro Kamiya | 2023-06-20 |
| 11673937 | Methods for expanding immune cells | Chihaya Imai | 2023-06-13 |
| 11648269 | T cell receptor-deficient chimeric antigen receptor T-cells and methods of use thereof | Takahiro Kamiya | 2023-05-16 |
| 11560548 | Immune cells expressing membrane-bound interleukin 15 (mbIL15) and uses thereof | David Shook, Masaru Imamura | 2023-01-24 |
| 11440958 | Blockade of CD7 expression and chimeric antigen receptors for immunotherapy of T-cell malignancies | Yi Tian Png, Natasha Vinanica, Takahiro Kamiya | 2022-09-13 |
| 11365236 | Truncated NKG2D chimeric receptors and uses thereof in natural killer cell immunotherapy | Jun Hao Leong, Noriko Shimasaki, See Voon Seow, James Barnaby Trager, Alexandra Leida Liana Lazetic +3 more | 2022-06-21 |
| 10836999 | Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious disease | Yu-Hsiang Chang | 2020-11-17 |
| 10829737 | Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious disease | Yu-Hsiang Chang | 2020-11-10 |
| 10801012 | Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious disease | Yu-Hsiang Chang | 2020-10-13 |
| 10774309 | Natural killer cell immunotherapy for treating cancer | Yu-Hsiang Chang | 2020-09-15 |
| 10774311 | Natural killer cells modified to express membrane-bound interleukin 15 and uses thereof | David Shook, Masaru Imamura | 2020-09-15 |
| 10765699 | Methods for enhancing efficacy of therapeutic immune cells | Takahiro Kamiya | 2020-09-08 |
| 10647997 | Modified effector cell (or chimeric receptor) for treating disialoganglioside GD2-expressing neoplasia | Massimo Dominici, Sara Caldrer, Maria Carlotta Spano, Paolo Paolucci, Marco Bestagno | 2020-05-12 |
| 10550183 | Blockade of CD7 expression and chimeric antigen receptors for immunotherapy of T-cell malignancies | Yi Tian Png, Natasha Vinanica, Takahiro Kamiya | 2020-02-04 |
| 10538739 | Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious disease | Yu-Hsiang Chang | 2020-01-21 |